US EditionAre Mesenchymal Stem/Stromal Cells a Novel Avenue for the Treatment of Non-Alcoholic Fatty Liver Disease?
Summary by Newswise
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Are Mesenchymal Stem/Stromal Cells a Novel Avenue for the Treatment of Non-Alcoholic Fatty Liver Disease?
In this editorial, we comment on the article by Jiang et al. Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease characterized by the accumulation of fat in the liver without evidence of significant alcohol consumption. NAF
·Charlottesville, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage